New Metabolic Disease Articles from our Partners at Consultant 360

Canagliflozin, Linagliptin Shown to Benefit CV and Renal Function

http://bit.ly/2LhMFCG

Encouraging findings from the CREDENCE and CARMELINA trials were presented at the American Diabetes Association’s 79th Scientific Sessions.

Type 2 Diabetes: Dulaglutide Found Beneficial for CVD, CKD Outcomes

http://bit.ly/2IbJOZS

The glucagon-like peptide-1 receptor agonist dulaglutide may benefit myriad patients with type 2 diabetes, according to highly anticipated findings from multiple trials presented at the American Diabetes Association’s 79th Scientific Sessions.

More Fruits, Vegetables Could Significantly Reduce CVD Deaths Globally

http://bit.ly/2IxmWDa

New findings presented at Nutrition 2019 may further support the benefits of eating “an apple a day,” as the adage says.

Plant-Based Eating May Help Prevent Type 2 Diabetes

http://bit.ly/2KeAGWC

Dietary patterns favoring plant food consumption are likely associated with a significant reduction in type 2 diabetes risk, according to new findings presented at Nutrition 2019.

Vitamin K May Actually Benefit Warfarin-Treated Patients

http://bit.ly/2ICxjFE

A small study presented at Nutrition 2019 suggests that, contrary to common belief, vitamin K intake may be beneficial in some cases for patients receiving the anticoagulant warfarin.